| Tag | Content |
|---|
EnhancerAtlas ID | HS134-00368 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:17493390-17494170 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:17493704-17493722 | CCCCCCTCCCTCCCTTCC | - | 6.14 | | RREB1 | MA0073.1 | chr1:17493797-17493817 | ACCCACACCGCCCCCCCCCC | + | 6.68 | | ZNF263 | MA0528.1 | chr1:17493688-17493709 | TCCCACCCTCTTCCCTCCCCC | - | 6.18 | | ZNF263 | MA0528.1 | chr1:17493699-17493720 | TCCCTCCCCCCTCCCTCCCTT | - | 6.69 | | ZNF263 | MA0528.1 | chr1:17493695-17493716 | CTCTTCCCTCCCCCCTCCCTC | - | 6.9 | | ZNF740 | MA0753.2 | chr1:17493804-17493817 | CCGCCCCCCCCCC | + | 6.64 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_47238 | chr1:17492726-17497965 | Panc1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I017166 | chr1 | 17493429 | 17497950 |
|
Enhancer Sequence | TAGGTGGCAC CAGTGGACAG CATAGAGTTG GAGAAGAATG AGCTCTGGGT CCTCAGGAAC 60
TCAACCTGTC CACCTCTTGC CACCTGATGC CCCTTCTCTA GTCCCAACTC TCATCAGCCC 120
CATCTAGCCC ACTGCATCTC CCTCTTTCCT GCCCTGCCTC CCTGGCATCC ACTCCCTGCA 180
GAGCATCCTG GGCTCAGAAC CTTGCAGTGA CTCCCACCTC GCTTGGAGTC AAAGCCAAAG 240
GGCACAACTG GCAAACAAGG CTCTCATCCC AGCCCCTGCC TGCTGCTTCT GTCTTTGATC 300
CCACCCTCTT CCCTCCCCCC TCCCTCCCTT CCTGGCCACA GAGGTCTTCT TGCAGCTCCC 360
TAAACCCTGG AGGCAATTTT CCAGCCCAGG GTCTTTGCAT AAACTCCACC CACACCGCCC 420
CCCCCCCGCC CCAACCTGGA ACGCTCTACT CCTGACAGTG TCTGGGGCTT TCTCATCCAA 480
GGTTTCAGCT TAAATGTTGC CTTGCCCAGG AGGCTTTCTC AGACCTCTTT ATTTGCTTCC 540
TTTACAGACC TAACCATGAT TTATAATTAA GTGTATTGTT TTAAAACTTA TTATCTCTTC 600
TCTTCACCAA TATGTCAGCT TCATGAGGAC AAAGCTCTGT CTGGCTCCTT ATTGCTACAT 660
CCCTAGAGCT CCAGGCAGTG CCTGACATCT AAATAGGCCT TTAGGTTAAA TGGAATTCTG 720
TGCTTTGACA TGAGGAAGGG AAATCAAGGA AGGCCCCCTG GAGGAGGTGT TTAGAGATGG 780
|
